CLINICAL_TRIALS
trial_result
· 2013-12-10
Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo Patients [Phase 2]
Summary
Phase 2 study evaluating topical minocycline FXFM244 in impetigo has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vyne Therapeutics Inc. | Conditions: Impetigo | Phase 2 | Status: COMPLETED